Myeloma evades T cell-engaging therapies

Nat Cancer. 2023 Nov;4(11):1534-1535. doi: 10.1038/s43018-023-00637-5.

Authors

Bruno Paiva¹, Jesús F San-Miguel²

Affiliations

¹ Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada, CCUN, Instituto de Investigacion Sanitaria de Navarra (IDISNA), Pamplona, Spain. bpaiva@unav.es.
² Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada, CCUN, Instituto de Investigacion Sanitaria de Navarra (IDISNA), Pamplona, Spain.

PMID: 37993694
DOI: 10.1038/s43018-023-00637-5

No abstract available

MeSH terms

Humans
Immunotherapy, Adoptive / adverse effects
Multiple Myeloma* / therapy
T-Lymphocytes